These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3536087)

  • 1. Differentiating agents in the treatment of human malignancies.
    Cheson BD; Jasperse DM; Chun HG; Friedman MA
    Cancer Treat Rev; 1986 Sep; 13(3):129-45. PubMed ID: 3536087
    [No Abstract]   [Full Text] [Related]  

  • 2. Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap.
    Browman GP; Levine MN; Roberts RS
    J Clin Oncol; 1986 Dec; 4(12):1730-1. PubMed ID: 3783200
    [No Abstract]   [Full Text] [Related]  

  • 3. Design of adjuvant chemotherapy based on target cell determinants of drug action: possibilities and limitations.
    Rustum Y; Cheng YC; Pavelic Z; Creaven P; Mihich E
    Recent Results Cancer Res; 1979; 67():126-31. PubMed ID: 377431
    [No Abstract]   [Full Text] [Related]  

  • 4. The conduct of therapeutic trials in cancer medicine.
    Rudnick S; Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):255-8. PubMed ID: 327556
    [No Abstract]   [Full Text] [Related]  

  • 5. The human tumor colony forming assay: review and clinical applications.
    Triedman JK; Witman GB; Chee DO; Triedman LJ
    R I Med J (1976); 1985 Aug; 68(8):361-6. PubMed ID: 3863223
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 7. The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
    Markman M
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):177-83. PubMed ID: 3892699
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing new drugs for ovarian cancer: a challenging task in a changing reality.
    Canetta RM; Carter SK
    J Cancer Res Clin Oncol; 1984; 107(2):111-24. PubMed ID: 6371015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tumor stem cell assay. A prospective clinical trial.
    Alonso K
    Cancer; 1984 Dec; 54(11):2475-9. PubMed ID: 6388806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukaemia Research Fund international research symposium on cytotoxic drug resistance in leukemia and other malignancies.
    Leukemia; 1989 Jun; 3(6):461-7. PubMed ID: 2566726
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of phase I and II clinical trials in cancer: a statistician's view.
    Geller NL
    Cancer Invest; 1984; 2(6):483-91. PubMed ID: 6509359
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of antineoplastic agents].
    Hermanský F
    Cas Lek Cesk; 1972 Nov; 111(45):1067-8. PubMed ID: 5084862
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical chemotherapy: its correlation with experimental models.
    Carter SK
    Recent Results Cancer Res; 1980; 74():31-6. PubMed ID: 7003660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia: a clinical and experimental evaluation of splenectomy and intensive chemotherapy.
    Brodsky I; Fuscaldo KE; Kahn SB; Conroy JF; Lamping CG
    Ser Haematol; 1975; 8(4):143-56. PubMed ID: 798283
    [No Abstract]   [Full Text] [Related]  

  • 15. Criticism of tumor response criteria raises trial design questions.
    Twombly R
    J Natl Cancer Inst; 2006 Feb; 98(4):232-4. PubMed ID: 16478740
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytosine arabinoside (NSC-63878)--clinical brochure.
    Livingston RB; Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug latentiation in cancer chemotherapy.
    Workman P; Double JA
    Biomedicine; 1978 Oct; 28(5):255-62. PubMed ID: 369628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].
    Inoue K; Ogawa M; Mukaiyama T; Mitsui I; Inagaki J; Horikoshi N
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):59-65. PubMed ID: 3889195
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro chemotherapy sensitivity testing for genitourinary malignancies.
    Lieber MM
    Prog Clin Biol Res; 1984; 153():51-65. PubMed ID: 6382286
    [No Abstract]   [Full Text] [Related]  

  • 20. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.